Tevogen Inc. SEC filings TVGNW

Tevogen Inc. has 309 filings in SEC EDGAR's recent list, going back to Jun 10, 2021. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change). The company's fiscal year ends on December 31.

Tevogen Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Nov 4, 2026 Nov 2, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Officer or director change
Nov 3, 2026 Oct 27, 2026
8-K Current report
Other events
Sep 30, 2026 Sep 29, 2026
8-K Current report
Officer or director change
Sep 16, 2026 Sep 14, 2026
8-K Current report
Other events
Sep 10, 2026 Sep 9, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Aug 26, 2026 Aug 24, 2026
S-8 Employee stock plan registration Aug 24, 2026 —
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
DEF 14A Proxy statement Aug 3, 2026 Aug 3, 2026
8-K Current report
Bylaw or fiscal year change
Jul 30, 2026 Jul 29, 2026
PRE 14A Preliminary proxy statement Jul 23, 2026 Jul 23, 2026
S-8 Employee stock plan registration Jul 10, 2026 —
424B3 Prospectus Jun 26, 2026 —
EFFECT Filing Jun 25, 2026 —
S-3 Shelf registration Jun 12, 2026 —
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-K/A Amended annual report Apr 30, 2026 Dec 31, 2025
8-K Current report
Listing notice
Apr 22, 2026 Apr 16, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
424B3 Prospectus Mar 25, 2026 —
8-K Current report
Other events
Mar 25, 2026 Mar 20, 2026
424B3 Prospectus Mar 4, 2026 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Mar 4, 2026 Mar 3, 2026
424B3 Prospectus Feb 26, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Feb 25, 2026 Feb 19, 2026
8-K Current report
Regulation FD disclosure
Jan 30, 2026 Jan 30, 2026
DEF 14A Proxy statement Jan 26, 2026 Jan 26, 2026
PRE 14A Preliminary proxy statement Jan 16, 2026 Dec 31, 2024
424B3 Prospectus Nov 14, 2025 —
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
424B3 Prospectus Sep 26, 2025 —
8-K Current report
Listing notice
Sep 26, 2025 Sep 23, 2025
424B3 Prospectus Aug 14, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
424B3 Prospectus Jul 10, 2025 —
8-K Current report
Other events
Jul 10, 2025 Jul 10, 2025
8-K Current report
Material agreement
Jul 3, 2025 Jul 3, 2025
424B5 Prospectus supplement Jul 3, 2025 —
8-K Current report
Other events
Jun 30, 2025 Jun 30, 2025
424B3 Prospectus Jun 27, 2025 —
EFFECT Filing Jun 26, 2025 —
CORRESP Letter to the SEC Jun 24, 2025 —
UPLOAD Letter from the SEC Jun 24, 2025 —
424B3 Prospectus Jun 23, 2025 —
8-K Current report
Shareholder vote results
Jun 23, 2025 Jun 23, 2025
S-3 Shelf registration Jun 20, 2025 —
424B3 Prospectus Jun 3, 2025 —
8-K Current report
Material agreement
Jun 3, 2025 May 30, 2025
424B3 Prospectus May 14, 2025 —
10-Q Quarterly report May 14, 2025 Mar 31, 2025
424B3 Prospectus May 7, 2025 —
EFFECT Filing May 2, 2025 —
S-8 Employee stock plan registration May 1, 2025 —
POS AM Filing Apr 30, 2025 —
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Apr 30, 2025
DEFA14A Additional proxy material Apr 25, 2025 —
8-K Current report
Bylaw or fiscal year change
Apr 25, 2025 Apr 21, 2025
8-K Current report
Regulation FD disclosure
Apr 17, 2025 Apr 17, 2025
10-K Annual report Apr 2, 2025 Dec 31, 2024
NT 10-K Filing Apr 1, 2025 Dec 31, 2024
424B3 Prospectus Jan 28, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jan 28, 2025 Jan 28, 2025
424B3 Prospectus Nov 19, 2024 —
10-Q Quarterly report Nov 19, 2024 Sep 30, 2024
NT 10-Q Filing Nov 15, 2024 Sep 30, 2024
424B3 Prospectus Aug 26, 2024 —
8-K/A Amended current report
Material agreement, Unregistered share sale
Aug 26, 2024 Aug 20, 2024
424B3 Prospectus Aug 23, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change
Aug 23, 2024 Aug 20, 2024
424B3 Prospectus Aug 14, 2024 —
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
424B3 Prospectus Aug 5, 2024 —
EFFECT Filing Aug 2, 2024 —
CORRESP Letter to the SEC Aug 1, 2024 —
S-1/A Amended registration statement Aug 1, 2024 —
CORRESP Letter to the SEC Jul 31, 2024 —
UPLOAD Letter from the SEC Jul 30, 2024 —
CORRESP Letter to the SEC Jul 29, 2024 —
UPLOAD Letter from the SEC Jul 24, 2024 —
S-1/A Amended registration statement Jul 23, 2024 —
CORRESP Letter to the SEC Jul 23, 2024 —
UPLOAD Letter from the SEC Jul 2, 2024 —
S-1 Registration statement Jun 21, 2024 —
8-K Current report
Material agreement, Agreement ended, Listing notice
Jun 21, 2024 Jun 14, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale
Jun 11, 2024 Jun 6, 2024
S-8 Employee stock plan registration Jun 10, 2024 —
8-K/A Amended current report May 30, 2024 Feb 14, 2024
10-Q Quarterly report May 28, 2024 Mar 31, 2024
NT 10-Q Filing May 16, 2024 Mar 31, 2024
8-K Current report
Material agreement
May 16, 2024 May 10, 2024
8-K Current report
Auditor change
May 2, 2024 Apr 29, 2024
8-K/A Amended current report Apr 29, 2024 Feb 14, 2024
10-K Annual report Apr 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Apr 26, 2024 Apr 26, 2024
8-K/A Amended current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
Apr 10, 2024 Mar 27, 2024
NT 10-K Filing Apr 2, 2024 Dec 31, 2023
8-K Current report
Material agreement, Bylaw or fiscal year change
Apr 2, 2024 Mar 27, 2024
8-K Current report
Bylaw or fiscal year change
Mar 21, 2024 Mar 15, 2024
8-K Current report Feb 21, 2024 Feb 14, 2024
8-K/A Amended current report
Material agreement, Unregistered share sale, Other events
Feb 20, 2024 Feb 14, 2024
CERT Filing Feb 15, 2024 —
8-A12B Filing Feb 14, 2024 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change
Feb 14, 2024 Feb 14, 2024
25-NSE Delisting notice Feb 14, 2024 —
425 Filing Feb 1, 2024 —
8-K Current report
Shareholder vote results, Regulation FD disclosure
Feb 1, 2024 Jan 31, 2024
425 Filing Jan 31, 2024 —
424B3 Prospectus Jan 24, 2024 —
425 Filing Jan 24, 2024 —
8-K Current report
Regulation FD disclosure
Jan 24, 2024 Jan 24, 2024
424B3 Prospectus Jan 24, 2024 —
424B3 Prospectus Jan 10, 2024 —
425 Filing Jan 5, 2024 —
8-K Current report
Regulation FD disclosure
Jan 5, 2024 Jan 4, 2024
EFFECT Filing Jan 4, 2024 —
CORRESP Letter to the SEC Jan 2, 2024 —
S-4/A Filing Dec 22, 2023 —
CORRESP Letter to the SEC Dec 22, 2023 —
425 Filing Dec 19, 2023 —
8-K/A Amended current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
Dec 19, 2023 Dec 14, 2023
425 Filing Dec 18, 2023 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
Dec 18, 2023 Dec 14, 2023
DEFR14A Filing Dec 13, 2023 —
UPLOAD Letter from the SEC Dec 4, 2023 —
DEF 14A Proxy statement Dec 4, 2023 Dec 4, 2023
UPLOAD Letter from the SEC Dec 4, 2023 —
PRER14A Filing Dec 1, 2023 —
PRER14A Filing Nov 27, 2023 —
CORRESP Letter to the SEC Nov 27, 2023 —
PRER14A Filing Nov 27, 2023 —
S-4/A Filing Nov 22, 2023 —
CORRESP Letter to the SEC Nov 21, 2023 —
UPLOAD Letter from the SEC Nov 20, 2023 —
425 Filing Nov 17, 2023 —
8-K Current report
Regulation FD disclosure
Nov 17, 2023 Nov 17, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
PRE 14A Preliminary proxy statement Nov 13, 2023 Nov 13, 2023
UPLOAD Letter from the SEC Nov 7, 2023 —
S-4/A Filing Oct 23, 2023 —
CORRESP Letter to the SEC Oct 23, 2023 —
10-Q/A Amended quarterly report Oct 23, 2023 Jun 30, 2023
UPLOAD Letter from the SEC Oct 11, 2023 —
8-K Current report
Other events
Sep 29, 2023 Sep 28, 2023
425 Filing Sep 14, 2023 —
8-K Current report
Regulation FD disclosure
Sep 14, 2023 Sep 14, 2023
S-4 Registration for a merger or exchange Sep 14, 2023 —
10-Q Quarterly report Aug 21, 2023 Jun 30, 2023
NT 10-Q Filing Aug 15, 2023 Jun 30, 2023
425 Filing Jul 12, 2023 —
425 Filing Jun 29, 2023 —
8-K Current report
Material agreement, Regulation FD disclosure
Jun 29, 2023 Jun 28, 2023
8-K Current report
Material agreement, Officer or director change
Jun 7, 2023 Jun 7, 2023
10-Q Quarterly report May 22, 2023 Mar 31, 2023
NT 10-Q Filing May 15, 2023 Mar 31, 2023
8-K Current report
Material agreement, Listing notice
May 9, 2023 May 4, 2023
10-K Annual report Apr 17, 2023 Dec 31, 2022
8-K Current report
Listing notice
Apr 7, 2023 Apr 4, 2023
NT 10-K Filing Mar 31, 2023 Dec 31, 2022
8-K Current report
Listing notice
Mar 29, 2023 Mar 23, 2023
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Feb 9, 2023 Feb 3, 2023
8-K Current report
Other events
Jan 31, 2023 Jan 30, 2023
DEFA14A Additional proxy material Jan 26, 2023 —
8-K Current report
Other events
Jan 26, 2023 Jan 26, 2023
DEF 14A Proxy statement Jan 20, 2023 Feb 3, 2023
PRE 14A Preliminary proxy statement Jan 10, 2023 Jan 10, 2023
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
10-Q Quarterly report May 17, 2022 Mar 31, 2022
NT 10-Q Filing May 17, 2022 Mar 31, 2022
8-K Current report
Officer or director change
Apr 15, 2022 Apr 13, 2022
10-K Annual report Apr 1, 2022 Dec 31, 2021
NT 10-K Filing Apr 1, 2022 Dec 31, 2021
8-K Current report
Other events
Dec 30, 2021 Dec 30, 2021
10-Q Quarterly report Dec 17, 2021 Sep 30, 2021
8-K Current report
Other events
Nov 15, 2021 Nov 8, 2021
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
Nov 8, 2021 Nov 3, 2021
424B4 Prospectus Nov 5, 2021 —
EFFECT Filing Nov 3, 2021 —
CERT Filing Nov 3, 2021 —
8-A12B Filing Nov 2, 2021 —
CORRESP Letter to the SEC Nov 1, 2021 —
CORRESP Letter to the SEC Nov 1, 2021 —
S-1/A Amended registration statement Oct 29, 2021 —
CORRESP Letter to the SEC Oct 28, 2021 —
UPLOAD Letter from the SEC Oct 28, 2021 —
S-1/A Amended registration statement Oct 27, 2021 —
CORRESP Letter to the SEC Oct 26, 2021 —
S-1/A Amended registration statement Oct 26, 2021 —
UPLOAD Letter from the SEC Oct 26, 2021 —
CORRESP Letter to the SEC Oct 22, 2021 —
S-1/A Amended registration statement Oct 22, 2021 —
UPLOAD Letter from the SEC Oct 20, 2021 —
CORRESP Letter to the SEC Oct 7, 2021 —
S-1 Registration statement Oct 7, 2021 —
DRS/A Filing Aug 17, 2021 —
UPLOAD Letter from the SEC Jul 8, 2021 —
DRS Filing Jun 10, 2021 —

Showing 198 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
TVGN (Nasdaq), TVGNW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Warren, NJ
SEC filer status
, Emerging growth company
SEC CIK
1860871
Former names
Tevogen Bio Holdings Inc. (until Jul 30, 2026); Semper Paratus Acquisition Corp (until Feb 15, 2024)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.